(866) 389-4659
Resources Pregnancy Guide Understanding Your Screenings Planning Hospital Bag Checklist Birth Plan Template
Cord Blood 101 Why Stem Cells Matter What Is Cord Blood? What Is Cord Tissue? Public vs. Private Banking Treatment & Research Cellular Materials Clinical Research StemCyte Biologics
Get Started Build Your Plan FAQ Advanced Protection Public Bank Access HLA Matching Newborn Genetic Analysis MaxCell® LifeSaver Guarantee Community Programs Special Programs Refer a Friend Public Banking Expanded Access Program
About Our Impact Who We Are Community Patient Stories
Build Your Plan
Newborn Genetic Analysis
NEWBORN GENETIC ANALYSIS

A fuller picture of your baby's genetic health

Screen your baby's DNA for over 200 genetic conditions at birth. Many of them are treatable when caught early.

STANDARD VS. EXPANDED SCREENING

Your state screens for some. NGA screens for more.

Hospital newborn screens are an important safety net. They catch many serious conditions early — but most states only look for around 30–60 disorders.

Newborn Genetic Analysis (NGA) goes further for families like you who want to prepare well. Using next-generation DNA sequencing on your baby's cord blood, NGA quietly checks for over 200 genetic conditions, including metabolic, blood, immune, cardiac, and neurological disorders that standard panels can miss.

Because NGA uses the cord blood already collected at birth, your baby doesn't need a separate blood draw. It's one more way your baby's cord blood can provide valuable health information from day one.

State heel prick test ~35
vs.
StemCyte NGA 200+
Conditions screened at birth
WHAT NGA SCREENS

258 genes. 9 categories. One test.

Select a category to explore what it covers.

258Total genes screened
148

Metabolic Disorders

PKU, CPT II deficiency, congenital hypothyroidism

Conditions related to enzyme deficiencies or substrate buildup. Early detection enables dietary modifications and enzyme replacement therapy.

Diet, enzyme replacement, surveillance
22

Immunodeficiency (SCID)

Agammaglobulinemia, Omenn syndrome

Inherited disorders causing severe defects in T and B cells. Treatable with antibiotics and stem cell transplantation when caught early.

Antibiotics, transplantation
22

Other Conditions

Cystic fibrosis, SMA, polycystic kidney disease

Complex disorders including kidney disease, muscular conditions, and respiratory conditions.

Surveillance, medication, transplantation
18

Hearing Loss

Connexin-related hearing loss, Pendred syndrome

Early-onset hearing loss genes. Early identification enables intervention before speech development is impacted.

Hearing aids, speech therapy
13

Pediatric Cancers

Retinoblastoma, neurofibromatosis, xeroderma pigmentosum

Genes associated with cancers that can develop in early childhood. Enables increased surveillance and screening.

Increased surveillance, screening
12

Blood Disorders

Thrombocytopenia, spherocytosis

Abnormal development of red blood cells or blood vessels leading to anemia, hemorrhaging, or hemolysis.

Surveillance, transfusions
10

Epilepsy

Seizure disorders, encephalopathy

Neurological disorders causing seizures. Early detection enables routine monitoring and medication.

Monitoring, anti-epileptic medication
8

Cardiac Conditions

Marfan syndrome, heart malformations

Congenital heart defects involving walls, valves, arteries, and veins of the heart.

Surgery, surveillance
4

Vision Loss

Oculocutaneous albinism, optic atrophy

Conditions affecting vision that can impact a child’s growth and development.

Dietary management, vision aids
WHY IT MATTERS

Early detection can change outcomes

Many genetic conditions are treatable when caught early. The challenge is catching them in the first place.

No extra procedure

NGA uses the cord blood already collected at birth. No heel prick, no additional blood draw for your baby.

Clinically curated

Only actionable, well-characterized variants are reported. Uncertain findings are excluded to avoid false alarms.

Physician-delivered

Results go directly to your doctor within 2–3 weeks. Your pediatrician guides any next steps.

CLIA-certified lab

NGA is performed by a CLIA-certified and CAP-accredited genetic testing laboratory.

HOW IT WORKS

Added at enrollment, done at delivery

1

Add NGA when you enroll

Select NGA as an Advanced Protection option with any cord blood banking plan. You can also add it anytime before your due date.

2

Cord blood is collected at birth

Your provider collects cord blood as part of the normal banking process. A small portion is set aside for genetic analysis.

3

DNA sequencing is performed

Next-generation sequencing screens 258 genes across 200+ conditions, covering metabolic, blood, immune, and other disorder categories.

4

Your doctor receives the report

A comprehensive report is delivered to your physician within 2–3 weeks. They'll walk you through any findings.

FREQUENTLY ASKED QUESTIONS

What parents ask

Hospital screenings (the "heel prick test") check for 30–60 conditions depending on your state, using metabolic markers. NGA uses next-generation DNA sequencing to screen for over 200 genetic conditions, providing a much broader picture of your baby's health.
No. NGA uses a small portion of the cord blood already collected at birth. There's no additional procedure for your baby.
Results are sent to your physician, who will discuss findings and any recommended follow-up with you directly. Early identification can open the door to proactive care and monitoring.
No. Variants of uncertain clinical significance (VUS) are excluded from your report. Only well-characterized, actionable findings are included.
No. Only a very small portion of the collected cord blood is used for genetic analysis. The remainder is processed and stored normally for banking.

A fuller picture of protection, from day one

$399

One-time Advanced Protection option with any cord blood banking plan

Add NGA to my plan